NCT04572542 2020-10-01Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric CancerThe First Affiliated Hospital of Xiamen UniversityPhase 1/2 Unknown46 enrolled